We are live on
!
Find out more
AAM
Ardevora Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
26.09%
This Fund
S&P 500
This Quarter
Est. Return
+31.72%
1 Year Est. Return
+26.09%
3 Year Est. Return
+39.37%
5 Year Est. Return
+181.14%
10 Year Est. Return
–
AUM
$5.11B
AUM Growth
+$1.34B
(+35%)
Cap. Flow
+$307M
Cap. Flow
% of AUM
6.02%
Top 10 Holdings %
Top 10 Hldgs %
10.52%
Holding
129
New
22
Increased
39
Reduced
56
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$46.3M |
| 2 |
Cisco
CSCO
|
+$43.8M |
| 3 |
AutoZone
AZO
|
+$42.5M |
| 4 |
Linde
LIN
|
+$42.3M |
| 5 |
Henry Schein
HSIC
|
+$42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$64.5M |
| 2 |
Dollar General
DG
|
+$57.3M |
| 3 |
MSCI
MSCI
|
+$55.2M |
| 4 |
Atlassian
TEAM
|
+$48.7M |
| 5 |
Repligen
RGEN
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.39% |
| 2 | Healthcare | 16.19% |
| 3 | Industrials | 14.76% |
| 4 | Consumer Discretionary | 13.07% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alibaba
BABA
$269B
| $60.5M | 1.18% |
280,635
+107,100
| +62% | +$22.3M |
|
2
Tandem Diabetes Care
TNDM
$1.17B
| $58.2M | 1.14% |
588,037
-83,999
| -12% | -$6.7M |
|
3
Spotify
SPOT
$99.2B
| $55.6M | 1.09% |
215,231
-82,869
| -28% | -$14.2M |
|
4
Electronic Arts
EA
$52.4B
| $53.1M | 1.04% |
402,303
+3,251
| +0.8% | +$384K |
|
5
Snap
SNAP
$7.32B
| $53.1M | 1.04% |
+2,260,615
| New | +$40.2M |
|
|
ATVI
6
DELISTED
Activision Blizzard
ATVI
| $51.5M | 1.01% |
678,500
-5,800
| -0.8% | -$405K |
|
7
Amazon
AMZN
$2.5T
| $51.5M | 1.01% |
373,060
-37,240
| -9% | -$4.5M |
|
8
Salesforce
CRM
$134B
| $51.4M | 1.01% |
274,498
+43,865
| +19% | +$7.39M |
|
9
Akamai
AKAM
$16.8B
| $51.4M | 1.01% |
479,808
+290,614
| +154% | +$29.2M |
|
10
Accenture
ACN
$89.9B
| $51.2M | 1% |
238,302
+28,506
| +14% | +$5.39M |
|
11
Lam Research
LRCX
$382B
| $51.1M | 1% |
1,578,620
+204,540
| +15% | +$5.58M |
|
12
Synopsys
SNPS
$71.5B
| $51.1M | 1% |
261,806
-72,935
| -22% | -$12M |
|
|
ZEN
13
DELISTED
ZENDESK INC
ZEN
| $50.6M | 0.99% |
571,731
-42,196
| -7% | -$3.25M |
|
14
Cognex
CGNX
$10.3B
| $50.5M | 0.99% |
845,686
-95,944
| -10% | -$5.21M |
|
15
Applied Materials
AMAT
$426B
| $50.3M | 0.98% |
831,321
-31,979
| -4% | -$1.73M |
|
16
Jack Henry & Associates
JKHY
$10.7B
| $50.2M | 0.98% |
272,557
-47,222
| -15% | -$8.23M |
|
17
Cadence Design Systems
CDNS
$90B
| $50.1M | 0.98% |
522,286
-161,114
| -24% | -$13.5M |
|
18
Workday
WDAY
$33.4B
| $50.1M | 0.98% |
267,502
-14,212
| -5% | -$2.3M |
|
19
Mercado Libre
MELI
$91.3B
| $49.9M | 0.98% |
50,629
-27,774
| -35% | -$20.8M |
|
20
Penumbra
PEN
$12.5B
| $49.7M | 0.97% |
277,870
-12,930
| -4% | -$2.24M |
|
21
Broadridge
BR
$17.2B
| $49.2M | 0.96% |
390,187
-37,293
| -9% | -$4.32M |
|
22
Elastic
ESTC
$6.1B
| $49.2M | 0.96% |
+533,805
| New | +$39M |
|
23
Verisk Analytics
VRSK
$26.4B
| $49.2M | 0.96% |
289,193
-22,394
| -7% | -$3.54M |
|
24
Fastenal
FAST
$54B
| $49.2M | 0.96% |
2,297,298
+58,498
| +3% | +$1.12M |
|
25
Becton Dickinson
BDX
$43.1B
| $48.8M | 0.95% |
208,920
+30,057
| +17% | +$7.24M |
|
Similar funds
TC
B
DI
DGAM
FAAM
SFG
BWM
SGCIA
Ardevora Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Ardevora Asset Management held 129 positions worth $5.11B, up 35% from $3.77B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Ardevora Asset Management deployed $307M of net new capital in Q2 2020, opening 22 new positions and adding to 39 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 104,857 shares worth $47.3M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was DexCom, an estimated $64.5M trimmed.
- Ardevora Asset Management's largest Q2 2020 buy was Bio-Rad Laboratories Class A: 104,857 shares worth $47.3M.
- Ardevora Asset Management added most to ResMed in Q2 2020, an estimated $40.7M increase.
- Ardevora Asset Management's biggest Q2 2020 reduction was DexCom, cutting an estimated $64.5M.
- Ardevora Asset Management fully exited Atlassian in Q2 2020, selling an estimated $48.7M.
- Ardevora Asset Management's ten largest holdings make up 11% of its $5.11B portfolio in Q2 2020.
- Ardevora Asset Management opened 22 new positions and closed 12 in Q2 2020.
- Ardevora Asset Management's portfolio value rose 35% quarter-over-quarter to $5.11B.
Based on Ardevora Asset Management's 13F filing for Q2 2020, filed 28 Jul 2020.